PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Yes exactly Gans.I emailed Endpoints about a year ago and...

  1. 74 Posts.
    lightbulb Created with Sketch. 11
    Yes exactly Gans.
    I emailed Endpoints about a year ago and they'd never heard of Paradigm or Pentosan Polysulphate in any trials!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.